Additionally, both PAX5 and MYC can be regulated by common signaling pathways, such as the B-cell receptor (BCR) and NF-κB pathways, further intertwining their expression and function in DLBCL (Liu et al., 2017) (Figure 4A). Here, PAX5 is linked to diffuse large B-cell lymphoma.